CHO Pharma
6586.TWO
1.61 USD
0.01
+0.63%
c
Overview
Last close
1.61 usd
Market cap
344.87M usd
52 week high
2.66 usd
52 week low
1.54 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
10344.524
Price/Book Value
3.9062
Enterprise Value
268.56M usd
EV/Revenue
8116.3249
EV/EBITDA
-34.5511
Key financials
Revenue TTM
33088.69 usd
Gross Profit TTM
N/A usd
EBITDA TTM
-6.64M usd
Earnings per Share
-0.04 usd
Dividend
N/A usd
Total assets
3.01B usd
Net debt
-95.99M usd
About
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan.
- Symbol6586.TWO
- ExchangeTWO
- IsinN/A
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Chung-Yi Wu Ph.D.
- HeadquarterTaipei
- Web sitehttps://www.chopharma.com
